Screening of nitrosamines by LC-HR-MS/MS technique – we detect trace amounts in active substances (APIs), products and raw materials.
We achieve high sensitivity, selectivity and precision by individually selecting method parameters depending on the drug and expected nitrosamines.
Quantitative analysis of proteins by LC-MS/MS. Targeted proteomics, biomarker determination, clinical sample analysis and quality control.
Sensitive and specific qualitative analysis of a broad profile of compounds in urine by LC-HR-MS/MS technique.
Maximize hardware and software capabilities to identify unknown substances.
Quantitative analysis of PQ500™ plasma proteins by LC-MS/MS – precision proteomics for diagnostics, biomarker analysis and clinical research.
If you want to perform quantitative, qualitative, or mixed LC-MS/MS analyses in a series of samples but don’t have the capabilities – this offer is for you.
Accurate, specific and multi-level identification of proteins and post-translational modifications by LC-HR-MS/MS. Comparative and statistical analyses.
Highly specific and sensitive qualitative LC-MS/MS analysis of product composition and supplement contaminants.
Monoclonal antibody analysis by LC-HR-MS/MS – MAM – glycosylations, peptide maps, disulfide bridges, PTMs, TiPOS studies, etc.
Our specialized service based on LC-MS/MS technique enables precise identification of the chemical structure of impurities present in samples of raw materials, active substances and finished drug products.
LC-HR-MS/MS lipid identification with CID and EAD fragmentation. Precision lipidomics – accurate annotation, profiling and expert support.